Thomas A. Raffin, Director at LUMOS PHARMA, INC. (LUMO), bought 1,150 shares at $8.46 ($10K) on 2022-08-25, disclosed to the SEC on 2022-08-26.
Open-market purchase of $10k LUMO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LDRH | SELL | 2015-02-23 | $8.5M | — | Filing → |
| LDRH | SELL | 2014-10-01 | $884K | — | Filing → |
| LDRH | SELL | 2014-09-26 | $6.2M | — | Filing → |